PT  - JOURNAL ARTICLE
AU  - Alphonce, Baraka
AU  - Meda, John
AU  - Nyundo, Azan
TI  - Correlates of the Post-Stroke cognitive impairment among patients with first-ever stroke admitted at tertiary hospitals in Dodoma, Tanzania: a prospective longitudinal study
AID  - 10.1101/2023.06.20.23291668
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.06.20.23291668
4099  - http://medrxiv.org/content/early/2023/06/22/2023.06.20.23291668.short
4100  - http://medrxiv.org/content/early/2023/06/22/2023.06.20.23291668.full
AB  - Introduction Stroke patients develop cognitive impairment that, significantly impacting their quality of life, their families, and the community as a whole, but they are not given attention. This study aims to determine the prevalence and predictors of post-stroke cognitive impairment (PSCI) among adult stroke patients admitted to a tertiary hospital in Dodoma, Tanzania.Methodology A prospective longitudinal study was conducted at tertiary hospitals in the Dodoma region, central Tanzania. A sample size of 158 participants with the first stroke confirmed by CT/MRI brain aged ≥ 18 years met the criteria. At baseline, social-demographic, cardiovascular risks and stroke characteristics were acquired and then at 30 days, participants were evaluated for depression and apathy.. Descriptive statistics were summarised as continuous data reported as Mean (SD) or Median (IQR), and categorical data were summarised using proportions and frequencies. Univariate and multivariable logistic regression analysis were computed to determine predictors of PSCIResults Of 158 participants, the mean age was 58.7 years, 57.6% were female, and 80.4% of participants met the criteria for post-stroke cognitive impairment. After multivariable logistic regression, left hemisphere stroke (AOR: 5.798, CI: 1.030 – 32.623, p = 0.046), a unit cm3 increase in infarct volume (AOR: 1.064, 95% CI: 1.018 – 1.113, p = 0.007), and apathy symptoms (AOR: 12.259, CI: 1.112 – 89.173, p = 0.041) had a significant association with PSCI.Conclusion The study showed a high prevalence of PSCI; profiling at-risk stroke survivors in a timely intervention may improve their prognosis. Future studies in the area would inform future interventions and policies.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0273200 Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Vice Chancellor's office at the University of Dodoma permitted the study after obtaining ethical clearance from the Directorate of Research and Publications (reference number MA.84/261/02). The administrative departments of Benjamin Mkapa and Dodoma Regional Referral Hospitals approved data collection with reference numbers AB.150/293/01/196 and EB.21/267/01/123, respectively. Participants were informed that their participation was fully optional and that they might opt out at any moment and their standard of care was unaffected by their decision to participate. Participants' names were substituted with identification numbers to ensure privacy and confidentiality. Stroke survivors who had depressed symptoms were referred to a psychiatrist for additional examination and treatment.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.All relevant data are within the manuscript and its Supporting Information files.